Daniel C. Martin
2021
Compensation breakdown
| Non-Equity Incentive Plan | $145,367 |
|---|---|
| Option Awards | $1,581,388 |
| Salary | $454,272 |
| Stock Awards | $473,266 |
| Other | $11,600 |
| Total | $2,665,893 |
Martin received $1.6M in option awards, accounting for 59% of the total pay in 2021.
Martin also received $145.4K in non-equity incentive plan, $454.3K in salary, $473.3K in stock awards and $11.6K in other compensation.
Rankings
In 2021, Daniel C. Martin's compensation ranked 4,898th out of 12,405 executives tracked by ExecPay. In other words, Martin earned more than 60.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,898 out of 12,405 | 61st |
Division Manufacturing | 2,049 out of 5,494 | 63rd |
Major group Chemicals And Allied Products | 867 out of 2,369 | 63rd |
Industry group Drugs | 777 out of 2,090 | 63rd |
Industry Pharmaceutical Preparations | 553 out of 1,537 | 64th |
Pay ratio
| Daniel C. Martin's Pay | $2,665,893 |
|---|---|
| Median Employee's Pay | $290,520 |
| Pay Ratio | 9to 1 |
In 2021, the annual total compensation of Daniel C. Martin was $2,665,893.
The annual total compensation of the median employee at Deciphera Pharmaceuticals was $290,520.
The ratio of Daniel C. Martin's pay to the pay of median employee was therefore 9 to one.
Martin's colleagues
We found four more compensation records of executives who worked with Daniel C. Martin at Deciphera Pharmaceuticals in 2021.